Literature DB >> 10048426

Histology according to the Revised European-American Lymphoma Classification significantly predicts the prognosis of ocular adnexal lymphoma.

M Nakata1, Y Matsuno, N Katsumata, T Takenaka, Y Kobayashi, M Narabayashi, Y Kagami, H Ikeda, A Kaneko, K Tobinai.   

Abstract

Lymphoid infiltrates in the ocular adnexa are mostly low-grade B-cell lymphoma, but their clinicopathologic characteristics and prognostic factors have not been extensively analyzed according to the Revised European-American Lymphoma (REAL) Classification. We reviewed histopathologic sections from 77 patients with primary ocular adnexal lymphoid infiltrates, and conducted univariate and multivariate analyses of possible prognostic factors. Fifty-seven of the 77 patients were confirmed to have malignant lymphoma. Histopathologic sections from 44 of the 57 patients were reclassified into the following categories; marginal zone lymphoma (MZL) in 35, mantle cell lymphoma (MCL) in two, diffuse large cell lymphoma (DLCL) in six, and lymphoplasmacytoid lymphoma (LPL) in one. In the remaining 13 patients, biopsied specimens were inadequate for further subclassification. The cause-specific survival rates of the 57 patients with primary ocular adnexal lymphoma at 5, 10, and 15 years were 90.1%, 84.8% and 84.8%, respectively. The univariate analysis showed that the clinical stage, serum lactate dehydrogenase (LDH) value and histopathologic subtype were significant. The 5-year cause-specific survival rate of the 35 patients with MZL was 100%, whereas that of the eight patients with non-MZL (DLCL and MCL) was 25% (p<0.0001). The multivariate analysis revealed that the histologic subtype (p=0.010) and serum LDH value (p=0.015) were independent significant predictors of survival. We conclude that malignant lymphomas occurring in the ocular adnexa histologically consist mostly of MZL. The histologic subtype according to the REAL Classification significantly predicts the prognosis of ocular adnexal lymphoma.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10048426     DOI: 10.3109/10428199909058411

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  13 in total

1.  Ocular adnexal marginal zone B cell lymphoma: a clinical and pathologic study of 23 cases.

Authors:  Frédéric Charlotte; Kamal Doghmi; Nathalie Cassoux; Hongtao Ye; Ming-Qing Du; Michèle Kujas; Annette Lesot; George Mansour; Phuc Lehoang; Nicole Vignot; Frédérique Capron; Véronique Leblond
Journal:  Virchows Arch       Date:  2005-12-02       Impact factor: 4.064

2.  Histopathological Features and Ann Arbor Stage in Periocular Lymphoma.

Authors:  Marco Zschoche; Annette Zimpfer; Björn O Scheef; Anselm M Jünemann; Rudolf F Guthoff; Christian Junghanss; Guido Hildebrandt; Steffen Emmert; Andreas Erbersdobler; Günther Kundt; Vinodh Kakkassery
Journal:  In Vivo       Date:  2020 Jul-Aug       Impact factor: 2.155

3.  Plasmacellular differentiation in extranodal marginal zone B cell lymphomas of the ocular adnexa: an analysis of the neoplastic plasma cell phenotype and its prognostic significance in 136 cases.

Authors:  S E Coupland; M Hellmich; C Auw-Haedrich; W R Lee; I Anagnostopoulos; H Stein
Journal:  Br J Ophthalmol       Date:  2005-03       Impact factor: 4.638

Review 4.  Ocular adnexal lymphomas: report of 2 cases of mantle cell lymphomas and short review of literature.

Authors:  Kamal Kant Sahu; Preithy Uthamalingam; Santhosh Sampath; Jitender Jinagal; Ashim Das; Gaurav Prakash; Pankaj Malhotra; Subhash Chander Varma
Journal:  Indian J Hematol Blood Transfus       Date:  2014-04-22       Impact factor: 0.900

Review 5.  Ocular adnexal marginal zone lymphoma of mucosa-associated lymphoid tissue.

Authors:  Dimitrios Kalogeropoulos; Alexandra Papoudou-Bai; Panagiotis Kanavaros; Chris Kalogeropoulos
Journal:  Clin Exp Med       Date:  2017-09-22       Impact factor: 3.984

6.  Ocular adnexal lymphoma: a clinicopathologic study of a large cohort of patients with no evidence for an association with Chlamydia psittaci.

Authors:  Manuel F Rosado; Gerald E Byrne; Feying Ding; Kenneth A Fields; Phillip Ruiz; Sander R Dubovy; Gale R Walker; Arnold Markoe; Izidore S Lossos
Journal:  Blood       Date:  2005-09-15       Impact factor: 22.113

7.  Prognostic value of cell-cycle markers in ocular adnexal lymphoma: an assessment of 230 cases.

Authors:  Sarah E Coupland; Martin Hellmich; Claudia Auw-Haedrich; William R Lee; Harald Stein
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2003-12-18       Impact factor: 3.117

Review 8.  Extranodal marginal zone lymphoma of the ocular adnexa.

Authors:  Alexandra Stefanovic; Izidore S Lossos
Journal:  Blood       Date:  2009-04-16       Impact factor: 22.113

Review 9.  A reappraisal of the diagnostic and therapeutic management of uncommon histologies of primary ocular adnexal lymphoma.

Authors:  Maurilio Ponzoni; Silvia Govi; Giada Licata; Silvia Mappa; Antonio Giordano Resti; Letterio S Politi; Lorenzo Spagnuolo; Eliana Di Cairano; Claudio Doglioni; Andrés J M Ferreri
Journal:  Oncologist       Date:  2013-06-28

Review 10.  [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].

Authors:  S E Coupland
Journal:  Ophthalmologe       Date:  2004-02       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.